Europe's biggest economy is heading into lockdown. Will recession follow? - CNN | Canada News Media
Connect with us

Economy

Europe's biggest economy is heading into lockdown. Will recession follow? – CNN

Published

 on


A version of this story first appeared in CNN Business’ Before the Bell newsletter. Not a subscriber? You can sign up right here.
What’s happening: Chancellor Angela Merkel said Sunday that Germany will go into a “hard” lockdown starting this week and continuing through the Christmas period. Non-essential shops and schools will be shut starting on Wednesday, and Christmas gatherings will be reduced from 10 people to only five from two different households.
The announcement comes after Germany recorded nearly 30,000 new coronavirus infections and almost 600 deaths within 24 hours on Friday, surpassing records.
Economy Minister Peter Altmaier said in an interview Monday that he thinks the country can avert another recession thanks to government support measures. Reuters reports that the number of people that will work reduced hours and have wages subsidized by the state is expected to rise.
“It is possible, if we act wisely, to once again preserve the economic substance of the country,” Altmaier said. But he stressed that this “depends very decisively on the further course of events.”
Given the extent of new restrictions, economists are worried.
“Germany must brace itself for a second recession,” Dr. Jörg Krämer, Commerzbank’s chief economist, told clients Monday.
Big picture: Germany isn’t the only country grappling with a spiraling health situation. South Korea has also sounded the alarm about rising cases and could announce new social distancing measures. And London’s mayor is asking the government to close schools for the holidays earlier than planned given a surge in infections in the city.
In the United States, as medical workers prepare to distribute the first doses of the Pfizer-BioNTech Covid-19 vaccine, the outlook for infections and hospitalizations remains extremely concerning. The country is nearing 300,000 deaths after hitting the 200,000 mark in September.
It’s a reminder that while the rollout of vaccines is an important moment in a devastating pandemic, it won’t be an immediate cure for the twin health and economic crises.
“After being the relative European success story in wave one, Germany has struggled over the last few weeks,” Deutsche Bank’s Jim Reid said in a research note Monday. The new lockdown, he said, would deal a short-term “blow to activity and confidence, even if the damage will be limited by knowledge of the imminent vaccine rollout.”

‘Blank check’ companies have billions to spend in 2021

On Wall Street, 2020 has become known as the year of the SPAC.
Special purpose acquisition companies, or so-called “blank check” firms tasked with cutting deals, have been all the rage. These companies raise funds from investors by going public, and then have two years to put that money to work.
According to Goldman Sachs, 206 SPACs have raised a record $70 billion in IPO proceeds this year, a fivefold increase from 2019. A record number of SPACs also announced or closed merger deals.
Remember: Companies like DraftKings and electric truck maker Lordstown Motors went public in 2020 by merging with SPACs, a faster route than a traditional IPO. Shares of both companies have skyrocketed since then, helping to drum up interest in the process.
The momentum is expected to continue into 2021, with a wall of capital still waiting to be deployed.
Goldman estimates that $61 billion in equity IPO proceeds raised by 205 SPACs “is currently searching for acquisition targets.” That cash needs to find a home in 2021 or 2022, or it will have to be returned to investors.
So far, electric and autonomous car companies have been among the most popular SPAC targets. But there’s only so many of those firms out there, which means the scope of interest will need to widen.
“[There’s an] imbalance between supply and demand, with more capital being raised and less obvious targets,” Dirk Albersmeier, JPMorgan’s co-head of global mergers and acquisitions, told me.
As competition for US takeover targets heats up, more of that money could head to Europe and Asia, Albersmeier noted.
Watch this space: Massive demand for high-growth companies is already reigniting conversation about whether valuations are too stretched and heading for a fall. Demand among SPACs may only feed those fears.
With so many SPACs focused on technology, and with a limited time frame to deploy capital, would-be buyers could end up “bidding themselves up,” Albersmeier said.

Pfizer and Moderna will cash in on vaccine sales

The authorization of Pfizer (PFE) and BioNTech’s Covid-19 vaccine in the United States is a momentous occasion for science, the economy and humanity. It’s also a big moneymaker for the companies that developed the vaccines, my CNN Business colleague Matt Egan reports.
Wall Street analysts project that Pfizer and Moderna (MRNA) — whose vaccine is next in line to be reviewed by regulators — will generate $32 billion in Covid-19 vaccine revenue next year alone.
That doesn’t take into account the goodwill boost these companies will receive by helping bring an end to the worst pandemic in a century. The effect is magnified for Moderna, a young biotech company that few people had heard of before 2020.
Investor insight: Pfizer’s stock is up just 10.7% this year, trailing the S&P 500’s 13.4% gain. But shares of German partner BioNTech, which trade in New York, have jumped more than 275%, valuing the company at $30.7 billion.
Moderna’s stock has skyrocketed 702% this year, giving the firm a market cap of $62.1 billion. Investors see the efficacy and safety results for its coronavirus vaccine as a validation of Moderna’s entire pipeline of products. They’re increasingly confident it won’t be the company’s only blockbuster.
But profits from vaccine sales are also drawing criticism. More than 1.6 million people have now died of Covid-19 globally.
“It is absolutely wrong for drug companies like Pfizer and Moderna to profiteer, and for their executives to make egregious personal fortunes, off of Covid-19 vaccines that have been so heavily subsidized and supported by American taxpayers,” said Eli Zupnick, a spokesman for Accountable.US, a progressive watchdog and patient advocacy group.
OPEC is due to release its monthly report after producers agreed to start pumping more oil in January.
Coming tomorrow: The European Commission is expected to publish sweeping new regulations targeting Facebook (FB), Google (GOOGL), Amazon (AMZN) and Apple (AAPL).

Let’s block ads! (Why?)



Source link

Continue Reading

Economy

Canada’s unemployment rate holds steady at 6.5% in October, economy adds 15,000 jobs

Published

 on

 

OTTAWA – Canada’s unemployment rate held steady at 6.5 per cent last month as hiring remained weak across the economy.

Statistics Canada’s labour force survey on Friday said employment rose by a modest 15,000 jobs in October.

Business, building and support services saw the largest gain in employment.

Meanwhile, finance, insurance, real estate, rental and leasing experienced the largest decline.

Many economists see weakness in the job market continuing in the short term, before the Bank of Canada’s interest rate cuts spark a rebound in economic growth next year.

Despite ongoing softness in the labour market, however, strong wage growth has raged on in Canada. Average hourly wages in October grew 4.9 per cent from a year ago, reaching $35.76.

Friday’s report also shed some light on the financial health of households.

According to the agency, 28.8 per cent of Canadians aged 15 or older were living in a household that had difficulty meeting financial needs – like food and housing – in the previous four weeks.

That was down from 33.1 per cent in October 2023 and 35.5 per cent in October 2022, but still above the 20.4 per cent figure recorded in October 2020.

People living in a rented home were more likely to report difficulty meeting financial needs, with nearly four in 10 reporting that was the case.

That compares with just under a quarter of those living in an owned home by a household member.

Immigrants were also more likely to report facing financial strain last month, with about four out of 10 immigrants who landed in the last year doing so.

That compares with about three in 10 more established immigrants and one in four of people born in Canada.

This report by The Canadian Press was first published Nov. 8, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

Health-care spending expected to outpace economy and reach $372 billion in 2024: CIHI

Published

 on

 

The Canadian Institute for Health Information says health-care spending in Canada is projected to reach a new high in 2024.

The annual report released Thursday says total health spending is expected to hit $372 billion, or $9,054 per Canadian.

CIHI’s national analysis predicts expenditures will rise by 5.7 per cent in 2024, compared to 4.5 per cent in 2023 and 1.7 per cent in 2022.

This year’s health spending is estimated to represent 12.4 per cent of Canada’s gross domestic product. Excluding two years of the pandemic, it would be the highest ratio in the country’s history.

While it’s not unusual for health expenditures to outpace economic growth, the report says this could be the case for the next several years due to Canada’s growing population and its aging demographic.

Canada’s per capita spending on health care in 2022 was among the highest in the world, but still less than countries such as the United States and Sweden.

The report notes that the Canadian dental and pharmacare plans could push health-care spending even further as more people who previously couldn’t afford these services start using them.

This report by The Canadian Press was first published Nov. 7, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

Trump’s victory sparks concerns over ripple effect on Canadian economy

Published

 on

 

As Canadians wake up to news that Donald Trump will return to the White House, the president-elect’s protectionist stance is casting a spotlight on what effect his second term will have on Canada-U.S. economic ties.

Some Canadian business leaders have expressed worry over Trump’s promise to introduce a universal 10 per cent tariff on all American imports.

A Canadian Chamber of Commerce report released last month suggested those tariffs would shrink the Canadian economy, resulting in around $30 billion per year in economic costs.

More than 77 per cent of Canadian exports go to the U.S.

Canada’s manufacturing sector faces the biggest risk should Trump push forward on imposing broad tariffs, said Canadian Manufacturers and Exporters president and CEO Dennis Darby. He said the sector is the “most trade-exposed” within Canada.

“It’s in the U.S.’s best interest, it’s in our best interest, but most importantly for consumers across North America, that we’re able to trade goods, materials, ingredients, as we have under the trade agreements,” Darby said in an interview.

“It’s a more complex or complicated outcome than it would have been with the Democrats, but we’ve had to deal with this before and we’re going to do our best to deal with it again.”

American economists have also warned Trump’s plan could cause inflation and possibly a recession, which could have ripple effects in Canada.

It’s consumers who will ultimately feel the burden of any inflationary effect caused by broad tariffs, said Darby.

“A tariff tends to raise costs, and it ultimately raises prices, so that’s something that we have to be prepared for,” he said.

“It could tilt production mandates. A tariff makes goods more expensive, but on the same token, it also will make inputs for the U.S. more expensive.”

A report last month by TD economist Marc Ercolao said research shows a full-scale implementation of Trump’s tariff plan could lead to a near-five per cent reduction in Canadian export volumes to the U.S. by early-2027, relative to current baseline forecasts.

Retaliation by Canada would also increase costs for domestic producers, and push import volumes lower in the process.

“Slowing import activity mitigates some of the negative net trade impact on total GDP enough to avoid a technical recession, but still produces a period of extended stagnation through 2025 and 2026,” Ercolao said.

Since the Canada-United States-Mexico Agreement came into effect in 2020, trade between Canada and the U.S. has surged by 46 per cent, according to the Toronto Region Board of Trade.

With that deal is up for review in 2026, Canadian Chamber of Commerce president and CEO Candace Laing said the Canadian government “must collaborate effectively with the Trump administration to preserve and strengthen our bilateral economic partnership.”

“With an impressive $3.6 billion in daily trade, Canada and the United States are each other’s closest international partners. The secure and efficient flow of goods and people across our border … remains essential for the economies of both countries,” she said in a statement.

“By resisting tariffs and trade barriers that will only raise prices and hurt consumers in both countries, Canada and the United States can strengthen resilient cross-border supply chains that enhance our shared economic security.”

This report by The Canadian Press was first published Nov. 6, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version